Delaware Business Court Insider | News
By Tom McParland | February 20, 2018
A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.
By Charles Toutant | February 9, 2018
The company artificially inflated its stock price by failing to disclose what it knew about links between cancer and Johnson's Baby Powder, according to the suit.
By Scott Graham | February 6, 2018
In an appellate showdown between Fish & Richardson's Juanita Brooks and MoloLamken's Jeffrey Lamken, a Federal Circuit panel seemed swayed by Merck's argument that one bad witness didn't taint the jury's verdict.
By Michael Booth | January 30, 2018
A New Jersey appeals court handed Swiss pharmaceutical giant Hoffmann-La Roche a minor victory when it affirmed a trial judge's ruling that four plaintiffs in the Accutane litigation blew the statute of limitations in filing their product liability lawsuits.
By David Gialanella | January 25, 2018
A trio of multibillion-dollar deals in three different industries led to a sharp increase in the total amount of value transacted in the 2017 mergers and acquisitions market in New Jersey, data shows.
By Michael Booth | January 25, 2018
New Jersey pharmaceutical regulators are proposing to closely monitor prescriptions for gabapentin, a drug that's nonaddictive but can be misused to enhance the effects of opioids and other addictive drugs.
By David J. Marella | January 22, 2018
OP-ED: An inside look from the Advisor to the Executive Director of the President's Commission on Combating Drug Addiction and the Opioid Crisis.
By Amanda Bronstad | January 19, 2018
A federal judge in Cleveland has appointed three special masters to help craft a settlement in the massive opioid litigation. One of them, Cathy Yanni, spoke to law.com about the complex case, which involves hundreds of cities, counties, states, Native American tribes and others that have sued manufacturers and distributors of the prescription painkillers.
By Lizzy McLellan | January 16, 2018
CEO Ajay Raju said his firm needed a presence along the New York-Philadelphia corridor and found an opportunity in Princeton's Smith, Stratton, Wise, Heher and Brennan.
By Lizzy McLellan | January 4, 2018
Will the Trump administration's policy change on marijuana put a chill on law firms' slow embrace of cannabis clients?
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...